Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · IEX Real-Time Price · USD

9.55

+0.07 (0.74%)

At close: May 2, 2024, 4:00 PM

9.46

-0.09 (-0.94%)

After-hours: May 2, 2024, 7:12 PM EDT

Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	128.03	393.64	595.08	7.23	16.57
Short-Term Investments	128.52	0	0	0	0
Cash & Cash Equivalents	256.55	393.64	595.08	7.23	16.57
Cash Growth	-34.83%	-33.85%	8134.15%	-56.39%	-
Other Current Assets	58.54	44.1	33.69	3.94	2.66
Total Current Assets	315.09	437.75	628.77	11.17	19.23
Property, Plant & Equipment	12.95	1.17	0.16	0	0
Other Long-Term Assets	32.2	5.39	0.7	0.55	0.5
Total Long-Term Assets	45.15	6.56	0.86	0.55	0.5
Total Assets	360.25	444.31	629.64	11.72	19.73
Accounts Payable	11.82	13.84	8.07	1.03	1.05
Current Debt	0	0	0	5.63	0.54
Other Current Liabilities	27.57	24.5	16.57	1.96	0.34
Total Current Liabilities	39.39	38.34	24.64	8.62	1.93
Long-Term Debt	84.59	69.8	75.7	0	3.62
Other Long-Term Liabilities	0.03	0	37.74	0	0.52
Total Long-Term Liabilities	84.62	69.8	113.44	0	4.13
Total Liabilities	124	108.14	138.08	8.62	6.07
Total Debt	84.59	69.8	75.7	5.63	4.16
Debt Growth	21.19%	-7.79%	1245.30%	35.30%	-
Retained Earnings	-752.95	-601.86	-385.65	-22.42	-11.86
Comprehensive Income	1.49	-1.5	0.69	0	0
Shareholders' Equity	236.24	336.17	491.55	3.1	13.66
Net Cash / Debt	171.96	323.84	519.38	1.6	12.41
Net Cash / Debt Growth	-46.90%	-37.65%	32361.38%	-87.11%	-
Net Cash Per Share	1.79	3.47	6.91	-	-
Working Capital	275.71	399.41	604.14	2.55	17.3
Book Value Per Share	2.46	3.60	6.54	0.04	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).